Minireviews
Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 7, 2013; 19(41): 7069-7077
Published online Nov 7, 2013. doi: 10.3748/wjg.v19.i41.7069
Advances in the management of acute liver failure
Da-Wei Wang, Yi-Mei Yin, Yong-Ming Yao
Da-Wei Wang, Department of ICU, Weihai Municipal Hospital, Weihai 264200, Shandong Province, China
Yi-Mei Yin, Department of Ultrasound, Weihai Municipal Hospital, Weihai 264200, Shandong Province, China
Yong-Ming Yao, Department of Microbiology and Immunology, Burns Institute, First Hospital Affiliated to the Chinese PLA General Hospital, Beijing 100048, China
Author contributions: Wang DW and Yin YM wrote the manuscript; Yao YM reviewed the drafts and made significant revisions.
Supported by National Natural Science Foundation of China, No. 81130035; the National Basic Research Program of China, No. 2012CB518102
Correspondence to: Yong-Ming Yao, MD, Department of Microbiology and Immunology, Burns Institute, First Hospital Affiliated to the Chinese PLA General Hospital, No. 51 Fucheng Road, Haidian District, Beijing 100048, China. c_ff@sina.com
Telephone: +86-10-66867394 Fax: +86-10-68989955
Received: May 9, 2013
Revised: August 5, 2013
Accepted: September 13, 2013
Published online: November 7, 2013
Processing time: 192 Days and 6.6 Hours
Abstract

Acute liver failure (ALF) is an uncommon but dramatic clinical syndrome characterized by hepatic encephalopathy and a bleeding tendency due to abrupt loss of liver function caused by massive or submassive liver necrosis in a patient with a previously healthy liver. The causes of ALF encompass a wide variety of toxic, viral, metabolic, vascular and autoimmune insults to the liver, and identifying the correct cause can be difficult or even impossible. Many patients with ALF develop a cascade of serious complications involving almost every organ system, and death is mostly due to multi-organ failure, hemorrhage, infection, and intracranial hypertension. Fortunately, the outcome of ALF has been improved in the last 3 decades through the specific treatment for the disease of certain etiology, and the advanced intensive care management. For most severely affected patients who fail to recover after treatment, rapid evaluation for transfer to a transplantation center and consideration for liver transplantation is mandatory so that transplantation can be applied before contraindications develop. This review focuses on the recent advances in the understanding of various contributing etiologies, the administration of etiology-specific treatment to alleviate the liver injury, and the management of complications (e.g., encephalopathy, coagulopathy, cardiovascular instability, respiratory failure, renal failure, sepsis and metabolic disturbance) in patients with ALF. Assessment of the need for liver transplantation is also presented.

Keywords: Acute liver failure; Cerebral edema; Liver transplantation

Core tip: Acute liver failure (ALF) is a dramatic clinical syndrome of abrupt loss of liver function in a patient with a previously healthy liver. The causes of ALF encompass a wide variety of toxic, viral, metabolic, vascular and autoimmune insults to the liver. ALF patients develop serious complications, and death is mostly due to sepsis, followed by multiple organ failure, and intracranial hypertension. However, disease outcome has been improved through etiological treatment and advanced intensive care management. For most severely affected patients who fail to recover after treatment, liver transplantation may be life-saving.